Navigation Links
Cuttlefish masters of disguise despite colorblindness

Cuttlefish are wizards of camouflage. Adept at blending in with their surroundings, cuttlefish are known to have a diverse range of body patterns and can switch between them almost instantaneously. New research from MBL Marine Resources scientists, to appear in the May 2006 issue of the journal Vision Research, confirms that while these masters of disguise change their appearance based on visual cues, they do so while being completely colorblind.

While previous research has reported cuttlefish colorblindness, MBL Research Associate Lydia Mäthger and her colleagues in Roger Hanlon's laboratory approached the problem in more depth and with a new behavioral assay. The researchers tested cuttlefish (Sepia officinalis) color perception through observing the animal's behavioral response to a series of checkerboard patterned substrates of various colors and brightnesses.

They found that the animals did not respond to the checkerboard pattern when placed on substrates whose color intensities were matched to the Sepia visual system, suggesting that these checkerboards appeared to their eyes as uniform backgrounds. However, their results showed that cuttlefish were able to detect contrast differences of at least 15%, which Mäthger and her colleagues suspect might be a critical factor in uncovering what determines camouflage patterning in cuttlefish.

Despite these results, the vexing question of how cuttlefish master the task of camouflage in low-contrast, color-rich environments such as those found at shallow depths of water, remains to be answered. Mäthger and her colleagues are currently looking at cuttlefish contrast sensitivity in more detail. "Our result that cuttlefish are able to detect contrast differences of at least 15%, is only an upper limit," says Mäthger. "It's certainly not the contrast threshold, which we would like to know. It seems that cuttlefish camouflage themselves by matching intensities of objects in the environment and we're col
'"/>

Source:Marine Biological Laboratory


Page: 1 2

Related biology news :

1. NSAID drug protects against intestinal tumors in mice, despite poor diet and gene losses
2. Fragile US vaccine system needs improvement despite dramatic gains in health over past century
3. Genetic testing still smart choice, despite uncertainties
4. Rhinos clinging to survival in the heart of Borneo, despite poaching
5. Chewing up a key regulator of fat synthesis keeps mice lean despite a high-fat diet
6. Beekeepers work hard for the honey, despite changing tupelo forest

Post Your Comments:
(Date:12/2/2009)...-American adolescents exposed to cigarette smoking...abit themselves, and this may be part of the accul...n, according to new study findings. , "Our study...ates and highlights the global implementation of t...on Tobacco Control, which includes guidelines for ...
(Date:12/2/2009)...9572; A Smoky Mountain forest,s woodland herb popu...ow forest understories recover from logging, accor...avy logging in portions of the forest nearly 80 ye...e secondary forest floor was similar to that of un...nt professor of forestry and natural resources, sa...
(Date:12/2/2009)...sed of undergraduate students from Stevens Institu...nal poster contest hosted by the International Soc...e annual contest highlights the research conducted...PE Annual Meeting in San Diego, Calif. , The win...ciate Ligament Tensioning Device," was presented b...
Breaking Biology News(10 mins):Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Study finds logging effects vary based on a forest's history, climate 2Richard T Crowder Joins Neogens Board of Directors 14944 1Richard T Crowder Joins Neogens Board of Directors 14944 2Lexicon to Present Positive Top Line Phase 2 Results for LX1031 in Non Constipating Irritable Bowel Syndrome at GASTRO 2009 6466 1Lexicon to Present Positive Top Line Phase 2 Results for LX1031 in Non Constipating Irritable Bowel Syndrome at GASTRO 2009 6466 2Lexicon to Present Positive Top Line Phase 2 Results for LX1031 in Non Constipating Irritable Bowel Syndrome at GASTRO 2009 6466 3Reported Use of AMAGs Feraheme 28ferumoxytol 29 Continues To Be Low But a Number of Nephrologists Are On the Verge of Use 6464 1Reported Use of AMAGs Feraheme 28ferumoxytol 29 Continues To Be Low But a Number of Nephrologists Are On the Verge of Use 6464 2
...in a western or southeastern state can pump as muc...s as the state,s entire motor vehicle traffic does...by scientists at the National Center for Atmospher...at Boulder. , The paper, "Estimates of CO2 from f... management," is being published online today in t...
... 1st and November 15th issues of Biophysical Journ...available online. Topics of interest include volt...synthetic drug design, the absence of large lipid ...porter dimmer. , Volume 93, Issue 9, November 1... channel in a Membrane Environment , Vishwanath Jo...
...des on a pair of plastic 3-D glasses and an uneart...t of a sci-fi horror flick -- seems to leap out of...his is no movie director,s fantasy. The horror ima...adly anthrax bacteria -- specifically one of its p...einberg School of Medicine are mapping parts of th...
Other Biology News:US fires release large amounts of carbon dioxide 2US fires release large amounts of carbon dioxide 3Media highlights in the November issues of Biophysical Journal 2Media highlights in the November issues of Biophysical Journal 3Northwestern to expose most deadly infectious diseases in 3-D 2Northwestern to expose most deadly infectious diseases in 3-D 3Northwestern to expose most deadly infectious diseases in 3-D 4
(Date:12/2/2009)...China, Dec. 2 /PRNewswire-Asia/ -- Simcere Pharmac... SCR ), a leading pharmaceutical company,speciali...ing of branded,generic and proprietary pharmaceuti...gs have been included in China,s National Drug Rei...a,s Ministry of Human Resources and Social,Securit...
(Date:12/2/2009)...e Scientist, a leading scientific magazine coverin...olve “Intelligent” EMCCD camera fourth...ations of 2009. , (PRWEB)...era from Photometrics ®, a designer and manu... for the life sciences, was ranked fourth among Th...
(Date:12/1/2009)...Nev., Dec. 1 PDL BioPhar...venue guidance for the fourth quarter ended Decemb...red with $69 million for the fourth quarter of 200... first of two installment payments of $12.5 millio...008 results was a one-time $1.8 million payment fr...
(Date:12/1/2009)...Dec. 1 Reportlinker.com announces ...its catalogue: ,, Emerging Clinical Trial Loca...anging healthcare and regulatory environment ,...linical-Trial-Locations---Eastern-Europe-Market-dy...environment.html ,, Over the last decade pharm...
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8
...h,Corporation (NYSE: SGP ) today announced the su...action with Virbac, S.A. to divest animal health,p...s were requested by the,European Commission as par... of Organon BioSciences N.V., In Europe, Virbac a...sulphonamide franchises of Intervet/Schering-Ploug...
...drenex,Pharmaceuticals set it sights on building a...," the small Durham company has signed its second ...elop a new compound for,hypertension and other pot...he hormone that triggers the "fight or,flight" rea...cientists,recognized this hormone, and its counter...
...y,Innovation Network (DVIN) announced today the aw...Wistar Institute will receive $89,000 to support t...gram, a two-year workforce,development program in ...rogram provides Community College of Philadelphia ... training while preparing for,careers as Biomedica...
Other Biology Technology:Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products 2Addrenex Pharmaceuticals Licenses New Compound to Sciele Pharma for the Treatment of Hypertension and Other Potential Indications 2Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar Institute 2Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar Institute 3
Mouse Anti-Human ZNF155 Monoclonal Antibody, Unconjugated, Clone 2F11 from Abnova Corporation
Mouse Anti-Human COASY Polyclonal Antibody, Unconjugated from Abnova Corporation
Rabbit Anti-Nonmuscle Myosin II Heavy Chain B (MHC-B) Polyclonal Antibody, Unconjugated from Covance Research Products, Inc
...educed and non-reduced forms. It does not react wi...Factor XIII is a Beta-globulin found in plasma and... catalytic subunit and is a dimmer of M.W. 160kDa....2 heterodimer (M.W. 320kDa); whereas in platelets,...
Biology Products: